First author, year, country | Study design | N | N with hearing loss (HL)* | Age (mean)† | Mode of vestibular assessment | STROBE quality | Vision assessment | Findings |
Bernard, 2015, France20 | R Cohort | 22 ScCMV 30 AcCMV | 48 (18 ears with MI/MO HL; 68 ears with SE/PR) CI use not reported | 34.7 months | Caloric EVAR HIT OVAR CVEMP | Low | Not assessed |
|
Dhondt, 2019, Belgium23 | Case Series | 4 ScCMV 1 AcCMV | 5 SE/PR (3 using CI) | 2–7.3 years | vHIT Rotatory test Caloric CVEMP OVEMP | Low | Not assessed |
|
Dhondt, 2021, Belgium19 | P Cohort | 41 ScCMV 52 AcCMV | 3 AcCMV (1 MO, 2 SE/PR) 14 ScCMV (1 MO, 13 SE/PR) ≥3 using CI | 7.2 months | vHIT Rotatory Test cVEMP | Moderate-low | Funduscopy |
|
Inoue, 2013, Japan17 | P Cohort | 8 cCMV | 8 PR (pre-CI) | 38 months | Damped Rotatory test Caloric cVEMP | Moderate-low | Not assessed |
|
Karltorp, 2014, Sweden22 | Case–control | 6 ScCMV 20 AcCMV 13 Controls (Cx26) | 26 SE (post-CI) cCMV 13 SE (post-CI) controls | 7.8 years | Movement ABC-2 Caloric vHIT cVEMP | Moderate-Low | Visual acuity Ocular alignment Funduscopy |
|
Laccourreye, 2015, France18 | R Cohort | 15 cCMV | 15 PR (pre-CI) | 14–36 months | Caloric | Moderate-low | Investigation not specified |
|
Maes, 2017, Belgium21 | Cross-sectional | 16 ScCMV 8 AcCMV 8 cCMV negative controls 8 Cx26 | 8 ScCMV (R ear 80 dB SD 27; L ear 68.8 SD 39.3)* 0 using CI | 6.7 months | cVEMP | Moderate | Visual-motor integration (Peasbody Developmental Motor Scale) |
|
Pappas, 1983, USA24 | Case–control | 19 AcCMV 17 cCMV negative controls | 14 (1 MI, 1 MO, 12 SE/PR) CI use not reported | 41 months | Caloric | Moderate–low | Not assessed |
|
Paul, 2017, France16 | R Cohort | 3 ScCMV 5 AcCMV | 8 (2 MO, 6 PR/total HL) CI use not reported | 18 months | Canal and otolithic tests | Moderate-low | Not reported |
|
Pinninti, 2021, USA11 | Case–control | 40 AcCMV 33 cCMV negative controls | 7 (2 MI, 2 MO/SE, 2 PR, 1 not reported) CI use not reported | 7.52 years | Rotatory test SVV cDVA cVEMP SOT BOT-2 | Moderate | Vestibulo-visual tract Gaze stability |
|
Strauss, 1985, USA9 | P Cohort | 6 ScCMV 5 AcCMV | 3 ScCMV (SE) CI use not reported | 22 months–8.5 years | Caloric | Low | Not assessed |
|
Zagólski 2007, Poland10 | Case–control | 10 ScCMV 16 AcCMV 40 cCMV negative controls | 8 ScCMV ears (SE/PR) CI use not reported | 3 months | Caloric cVEMP | Moderate | Not assessed |
|
Study design: R=retrospective; P=prospective.
Hearing loss=severity reported where available.
For mode of vestibular assessment, please see appendix A for glossary of vestibular and balance investigations.
Findings: (n)=number of cCMV cases out of N, where number of children tested is different to N, (n out of….) is reported.
*Where only mean decibel (dB) hearing threshold was reported, this can be interpreted as: <20 dB=normal; 21–40 dB=mild; 41–70 dB=moderate; 71–90 dB=severe; 91–119 dB=profound (Bernard, 2015).
†Range (where mean not reported).
ABC, assessment battery for children; AcCMV, asymptomatic cCMV; BOT-2, bruininks-oseretsky test of motor proficiency, second edition (BOT-2); cDVA, clinical dynamic visual acuity; CI, cochlear implant; cVEMP, cervical vestibular myogenic evoked potential; Cx26, connexin 26 mutation; EVAR, earth vertical axis rotation; HL, hearing loss; MI, mild; MO, moderate; N, number of cCMV cases; NH, normal hearing; OVAR, off vertical axis rotation; oVEMP, ocular vestibular myogenic evoked potential; P, prospective; PR, profound; R, retrospective; ScCMV, symptomatic CMV; SE, severe; SOT, sensory organisation test; SVV, subjective visual vertical; vHIT, video head impulse testing ; VOR, vestibulo-ocular reflex.